Syngenta Launches First Commercial Product Since Pasteuria Acquisition

Syngenta, a Swiss agribusiness company, has launched its first commercial product since acquiring Alachua-based Pasteuria Bioscience in September 2012 for $113 million.

The breakthrough seed treatment, CLARIVA, is based on Pasteuria technology and will act as a nematicide. CLARIVA consists of naturally occurring soil bacteria that causes a negative effect on nematodes: microscopic worm-shaped soil organisms that cause significant damage to all major agricultural crops.

It’s initial launch in the United States will be for use on soybeans, with further registrations pending.

“Soybean growers in particular have long been searching for additional tools to manage the widespread cyst nematode problem, which in the USA alone causes more than a $1 billion of annual yield losses” said John Atkin, Syngenta’s chief operating officer, in a press release. “CLARIVA will take nematode control to a new level and reinforce our global leadership in seed treatment innovation.”

CLARIVA will be available in the United State for the 2014 growing season. The nematicide will be combined with other leading Syngenta seed care compounds as a complete solution for soybeans.


Related posts